Home > Category > Signaling Pathways > Microbiology/Virology > HIV Protease > Emtricitabine (BW1592)

Emtricitabine (BW1592)

ChemLeader 98+%
Catalog No:CL2541 CAS No.:143491-57-0 MDLNo: Formula:C8H10FN3O3S MW:247.25
Size Availability Price(USD) VIP Price (USD) Quantity
500 mg 3-5days $150.00 Visible after login
- +
1 g 3-5days $200.00 Visible after login
- +
5 g 3-5days $300.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Emtricitabine (BW1592)
CAS143491-57-0
FormulaC8H10FN3O3S
MW247.25
AppearanceWhite to off-white powder
Storage conditionDry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
Product details

Emtricitabine (BW1592; FTC; Coviracil; Emtriva; Racivir) is a potent nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 µM and has been used for the treatment of both human immunodeficiency virus (HIV) and hepatitis B virus. Emtricitabine is structurally similar to Lamivudine. It is effective at targeting HIV and HBV viruses since these viruses replicate in a reverse transcriptase manner. Studies indicate that the structure of Emtricitabine, specifically the unnatural β-L structural configuration produce greater antiviral effects in vitro on HIV and HBV than other antiviral agents. nucleoside reverse transcriptase inhibitor.

Related literature
Sorry, there is no relevant literature
Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays